Next 10 |
2024-04-15 07:48:18 ET Shah Capital, a top-five shareholder in Novavax ( NASDAQ: NVAX ), is pushing for an urgent board shake-up at the company, citing the “underperformance of the business and the current management’s failure to capitalize on its competitive advantage...
Believes the two new nominated directors possess the necessary experience to tackle the underperformance of the business which will improve its share price Shah Capital which owns 6.7% of Novavax, in a letter to the board says that the low share price reflects the board and management...
2024-04-13 16:22:00 ET If there is one thing Bluebird Bio (NASDAQ: BLUE) and Novavax (NASDAQ: NVAX) have in common, other than their belonging to the biotech industry, it is that both have seen their shares drop catastrophically in recent years. Bluebird's stock is down by 9...
2024-04-12 06:35:00 ET In just the past 12 months, Novavax (NASDAQ: NVAX) stock has plummeted 48% in value. The once-promising COVID vaccine maker has struggled mightily; it was late to getting a vaccine approved and to market, and now with some concerns relating to COVID subsiding,...
2024-04-02 10:15:00 ET Sometimes it is worth it to buy shares of companies on the dip, and sometimes it isn't. It all depends on whether there are good reasons to believe the company in question will bounce back, and if it will, there is arguably no better time to invest than when it is dow...
Novavax Presents Data on Updated COVID-19 Vaccine and Progress to Date on its COVID-19-Influenza Combination Vaccine Candidate at World Vaccine Congress 2024 PR Newswire GAITHERSBURG, Md. , April 1, 2024 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global comp...
2024-03-09 01:59:00 ET Investing basics tell us to "buy low" and invest in a stock when there looks to be significant upside potential. That can often be after a company gets put through the wringer and the stock declines substantially. However, sometimes it's not worth investing in a compa...
2024-03-07 13:29:15 ET More on AstraZeneca, CSL, etc. Sanofi (SNY) TD Cowen 44th Annual Health Care Conference (Transcript) GSK Plc: An Undervalued Vaccine Behemoth That Is Resuming Growth; Buy CSL Limited: Earnings Beat Doesn't Mask Unfavorable Trial Results (Downgr...
2024-03-06 16:43:13 ET Novavax, Inc. (NVAX) TD Cowen's 44th Annual Health Care Conference Call March 06, 2024, 1:30 PM ET Company Participants John Jacobs - President and Chief Executive Officer Filip Dubovsky - President, Research and Development Jim Kelly - Exe...
2024-03-05 08:09:09 ET More on BioNTech, Moderna, etc. Pfizer Inc. (PFE) TD Cowen 44th Annual Health Care Conference 6%-Yielding Pfizer Is An Ultra-Deep-Value Gem In An Expensive Market Novavax: Another Day Older And Deeper In Biden to launch task force to ta...
News, Short Squeeze, Breakout and More Instantly...
Believes the two new nominated directors possess the necessary experience to tackle the underperformance of the business which will improve its sh...
Believes the two new nominated directors possess the necessary experience to tackle the underperformance of the business which will improve its share price Shah Capital which owns 6.7% of Novavax, in a letter to the board says that the low share price reflects the board and management...
2024-04-13 16:22:00 ET If there is one thing Bluebird Bio (NASDAQ: BLUE) and Novavax (NASDAQ: NVAX) have in common, other than their belonging to the biotech industry, it is that both have seen their shares drop catastrophically in recent years. Bluebird's stock is down by 9...